[Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples